Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin

por Langenfeld, Elaine, Deen, Malik, Zachariah, Emmanuel, Langenfeld, John
Publicado 2013

Bone Morphogenetic Protein Type I Receptor Antagonists Decrease Growth and Induce Cell Death of Lung Cancer Cell Lines

por Langenfeld, Elaine, Hong, Charles C., Lanke, Gandhi, Langenfeld, John
Publicado 2013

Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death

por Augeri, Dave J., Langenfeld, Elaine, Castle, Monica, Gilleran, John A., Langenfeld, John
Publicado 2016

Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis...

por NeMoyer, Rachel, Mondal, Arindam, Vora, Mehul, Langenfeld, Elaine, Glover, Danea, Scott, Michael, Lairson, Lauren, Rongo, Christopher, Augeri, David J., Peng, Youyi, Jabbour, Salma K., Langenfeld, John
Publicado 2019

Bone morphogenetic protein receptor 2 inhibition destabilizes microtubules promoting the activation of lysosomes and cell death of lung cancer cells

por Mondal, Arindam, NeMoyer, Rachel, Vora, Mehul, Napoli, Logan, Syed, Zoya, Langenfeld, Elaine, Jia, Dongxuan, Peng, Youyi, Gilleran, John, Roberge, Jacques, Rongo, Christopher, Jabbour, Salma K., Langenfeld, John
Publicado 2021